GILT Docetaxel - Non-Small Cell Lung Cancer
NCT00174629
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
449
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Neoplasms
Interventions
DRUG:
Docetaxel/DDP
DRUG:
docetaxel/gemcitabine
Sponsor
Sanofi